Company: EUDAW
Filing Date: 2025-09-24
Form Type: 20-F/A
Source: 0001493152-25-014808
Chunk: 45

Company: EUDA Health Holdings Ltd
Filing Date: 2025-09-24
Form: 20-F/A
Chunk 45
---
 Hence, CKHP    
 considered the fair value of the contingent consideration to be $0.                                                                   |

The purchase price was allocated to the assets and identifiable intangible assets acquired, and liabilities assumed, based on their relative fair values at the acquisition date. The Company considered the fair value of identifiable intangible assets is lower than their allocated relative fair values and recorded an impairment loss of $ 14,755,560on these intangible assets related to the acquisition. As a result, no goodwill was recorded for the excess value of the consideration transferred over the fair value of net assets acquired, as the transaction was recognized as an asset acquisition under ASC 805 rather than a business combination.

The identifiable intangible assets, consisting of distribution contracts with Guangzhou Beauty Wellness Health Technology Co., Ltd (“GBHT”) and Guangzhou Yoroyal Medical Technology Co., Ltd (“Yoroyal”), were recognized with fair values of $ 279,025and $ 58,803, respectively, net of impairment loss. These distribution contracts are amortized based on the pattern of economic benefit, with useful lives estimated at two years for GBHT and three years for Yoroyal. The income method, typically used for valuing intangible assets that generate the majority of economic benefits for the acquiring entity, was applied to assess these assets.

Note 7 – Accounts receivable, net

Accounts receivable consist of the following:

Schedule of accounts receivable

|                                |     |   |        As of 
 December 31, 
         2024 |   |     |   |        As of 
 December 31, 
         2023 |   |
|:-------------------------------|:----|:--|-------------:|:--|:----|:--|-------------:|:--|
| Accounts receivable            |     | $ |      148,594 |   |     | $ |      239,978 |   |
| Allowance for credit losses    |     |   |       (2,420 | ) |     |   |       (2,504 | ) |
| Total accounts receivable, net |     | $ |      146,174 |   |     | $ |      237,474 |   |

As of December 31, 2024 and 2023, the Company had allowance for credit losses of $ 2,420and $ 2,504, respectively.

Movements of allowance for credit losses from accounts receivable are as follows:

Schedule of movements of allowance for doubtful